Ribavirin monotherapy for the treatment of chronic hepatitis E in an immunosuppressed patient

Rev Esp Enferm Dig. 2021 May;113(5):386-387. doi: 10.17235/reed.2020.7266/2020.

Abstract

We herein report the case of a 54-year-old male patient with a human immunodeficiency virus 1 (HIV-1) infection, usually with low viral loads and CD4 cells < 200-100/mm3 due to thymic exhaustion. He was referred to our clinic because of hypertransaminasemia and cholestasis of a duration of 58 months and liver cirrhosis on FibroScan® without esophageal varices. Nonspecific manifestations included weight loss. Liver disease stigmata and generalized amyotrophy were also present.

Publication types

  • Case Reports

MeSH terms

  • Antiviral Agents / therapeutic use
  • HIV Infections* / complications
  • HIV Infections* / drug therapy
  • Hepatitis E* / complications
  • Hepatitis E* / drug therapy
  • Humans
  • Immunocompromised Host
  • Liver Cirrhosis / drug therapy
  • Male
  • Middle Aged
  • Ribavirin / therapeutic use

Substances

  • Antiviral Agents
  • Ribavirin